Skip to Main Content

Paper Details

A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
Int J Radiat Oncol Biol Phys
21
2023
Author NameAffiliation
Daniel A LowUniversity of California los angeles
Yingli Yanguniversity of california los angeles David Geffen School of Medicine
Kyle R PadgettSylvester Comprehensive Cancer Center, Miller School of Medicine
Joseph D ManciasBrigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School
Adam C MuellerSidney Kimmel Cancer Center, Thomas Jefferson University
  • 1 - 5

Datasets